Page last updated: 2024-10-17

2-aminoadipic acid and Glioblastoma

2-aminoadipic acid has been researched along with Glioblastoma in 1 studies

2-Aminoadipic Acid: A metabolite in the principal biochemical pathway of lysine. It antagonizes neuroexcitatory activity modulated by the glutamate receptor, N-METHYL-D-ASPARTATE; (NMDA).
2-aminoadipic acid : An alpha-amino acid that is adipic acid bearing a single amino substituent at position 2. An intermediate in the formation of lysine.

Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rosi, A1
Ricci-Vitiani, L1
Biffoni, M1
Grande, S1
Luciani, AM1
Palma, A1
Runci, D1
Cappellari, M1
De Maria, R1
Guidoni, L1
Pallini, R1
Viti, V1

Other Studies

1 other study available for 2-aminoadipic acid and Glioblastoma

ArticleYear
(1) H NMR spectroscopy of glioblastoma stem-like cells identifies alpha-aminoadipate as a marker of tumor aggressiveness.
    NMR in biomedicine, 2015, Volume: 28, Issue:3

    Topics: 2-Aminoadipic Acid; Adult; Aged; Biomarkers, Tumor; Brain Neoplasms; Cell Survival; Female; Glioblas

2015